Allergan.com

There’s plenty of speculation whether Allergan CEO Brent Saunders will become CEO of Pfizer—and how quickly—when the two companies consummate their $160 billion tax-inversion merger, which they hope to consummate later this year. But at an early morning...

Actavis Plc (NYSE:ACT) with its market capitalization of $73.10B is a specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. Its business is focused principally in the Urology and...

ValueAct Capital will return to Valeant Pharmaceutical’s board room, with the hedge fund expressing its desire to work with the pharmaceutical giant to try and secure the acquisition of Allergan Inc. Allergan, the botox maker, has rejected numerous...

GREENVILLE, N.C. — Mayne Pharma has completed its purchase of a package of generic drug products from Teva Pharmaceutical Industries Ltd. and Allergan plc. Stefan Cross Mayne said Wednesday that under the $652 million deal, announced in late June,...

Teva Pharmaceutical Industries — the world’s biggest generic drug maker — announced the biggest acquisition ever by an Israeli company. On Monday, the company revealed plans to purchase Allergan Generics — another generic drug maker — for $40.5 billion...